rs117433399
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_005559.4(LAMA1):āc.5867A>Gā(p.Asn1956Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00217 in 1,614,174 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005559.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMA1 | NM_005559.4 | c.5867A>G | p.Asn1956Ser | missense_variant | 41/63 | ENST00000389658.4 | NP_005550.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMA1 | ENST00000389658.4 | c.5867A>G | p.Asn1956Ser | missense_variant | 41/63 | 1 | NM_005559.4 | ENSP00000374309.3 | ||
LAMA1 | ENST00000579014.5 | n.6882A>G | non_coding_transcript_exon_variant | 40/62 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00135 AC: 206AN: 152180Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00149 AC: 374AN: 251492Hom.: 2 AF XY: 0.00144 AC XY: 196AN XY: 135922
GnomAD4 exome AF: 0.00225 AC: 3289AN: 1461876Hom.: 5 Cov.: 32 AF XY: 0.00224 AC XY: 1631AN XY: 727244
GnomAD4 genome AF: 0.00135 AC: 206AN: 152298Hom.: 1 Cov.: 32 AF XY: 0.00114 AC XY: 85AN XY: 74490
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:4
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | LAMA1: BP4, BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Dec 28, 2016 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 27, 2018 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
LAMA1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 26, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at